Tumor protein D52 (TPD52): A novel B-cell/plasma-cell molecule with unique expression pattern and Ca2+-dependent association with annexin VI

Blood

Volumn 105, Issue 7, 2005, Pages 2812-2820

  Tiacci, Enrico ^b   Orvietani, Pier Luigi ^b   Bigerna, Barbara ^b   Pucciarini, Alessandra ^b   Corthals, Garry L ^b   Pettirossi, Valentina ^b   Martelli, Maria P ^b   Liso, Arcangelo ^b   Benedetti, Roberta ^b   Pacini, Roberta ^b   Bolli, Niccolò ^b   Pileri, Stefano ^b   Pulford, Karen ^b   Gambacorta, Marcello ^b   Carbone, Antonino ^b   Pasquarello, Carla ^b   Scherl, Alexander ^b   Robertson, Helen ^b   Sciurpi, Maria Teresa ^b   Alunni Bistocchi, Giovanni ^b   Binaglia, Luciano ^b   Byrne, Jennifer A ^b   Falini, Brunangelo ^a   more..

^a POLICLINICO MONTELUCE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CALCIUM ION; CALPHOBINDIN II; CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD79A ANTIGEN; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN SUPERFAMILY RECEPTOR TRANSLOCATION ASSOCIATED 1 RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B28P; TRANSCRIPTION FACTOR PAX5; TUMOR PROTEIN; TUMOR PROTEIN D52; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CALCIUM SIGNALING; CELL SECRETION; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC TISSUE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MASS SPECTROMETRY; MOUSE; MUCOSA ASSOCIATED LYMPHOID TISSUE; MYELOMA CELL; NEOPLASM; NONHUMAN; NORMAL HUMAN; PLASMA CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

EID: 20144388563     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2630     Document Type: Article

References (50)

1. Calame KL. Plasma cells: finding new light at the end of B cell development. Nat Immunol. 2001;2: 1103-1108.
2. Lin KI, Angelin-Duclos C, Kuo TC, Calame K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol Cell Biol. 2002;22:4771-4780.
3. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
4. Jaffe E, Harris NL, Stein H, Vardiman JW. Tumors of haematopoietic and lymphoid tissues. WHO Classification of Tumors. Lyon, France: IARC Press; 2001.
5. Sebestyen A, Berczi L, Mihalik R, Paku S, Matolcsy A, Kopper L. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas. Br J Haematol. 1999;104:412-419.
6. Turley H, Jones M, Erber W, Mayne K, de Waele M, Gatter K. VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections. J Clin Pathol. 1994;47: 418-422.
7. Banham AH, Turley H, Pulford K, Gatter K, Mason DY. The plasma cell associated antigen detectable by antibody VS38 is the p63 rough endoplasmic reticulum protein. J Clin Pathol. 1997;50: 485-489.
8. Falini B, Fizzotti M, Pucciarini A, et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood. 2000;95:2084-2092.
9. Hatzivassiliou G, Miller I, Takizawa J, et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity. 2001;14:277-289.
10. Falini B, Tiacci E, Pucciarini A, et al. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood. 2003;102:3684-3692.
11. Byrne JA, Tomasetto C, Garnier JM, et al. A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence. Cancer Res. 1995;55:2896-2903.
12. Chen SL, Maroulakou IG, Green JE, et al. Isolation and characterization of a novel gene expressed in multiple cancers. Oncogene. 1996;12: 741-751.
13. Wilson SH, Bailey AM, Nourse CR, Mattei MG, Byrne JA. Identification of MAL2, a novel member of the mal proteolipid family, though interactions with TPD52-like proteins in the yeast two-hybrid system. Genomics. 2001;76:81-88.
14. Thomas DD, Kaspar KM, Taft WB, Weng N, Rodenkirch LA, Groblewski GE. Identification of annexin VI as a Ca2+-sensitive CRHSP-28-binding protein in pancreatic acinar cells. J Biol Chem. 2002;277:35496-35502.
15. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984;32: 219-229.
16. Balleine RL, Fejzo MS, Sathasivam P, Basset P, Clarke CL, Byrne JA. The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma. Genes Chromosomes Cancer. 2000; 29:48-57.
17. Falini B, Abdulaziz Z, Gerdes J, et al. Description of a sequential staining procedure for double immunoenzymatic staining of pairs of antigens using monoclonal antibodies. J Immunol Methods. 1986;93:265-273.
18. Hochstrasser DF, Harrington MG, Hochstrasser AC, Miller MJ, Merril CR. Methods for increasing the resolution of two-dimensional protein electrophoresis. Anal Biochem. 1988;173:424-435.
19. Moritz R, Eddes J, Ji H, Reid GE, Simpson RJ. Rapid separation of proteins and peptides using conventional silica-based supports: identification of 2-D gel proteins following in-gel proteolysis. In: Crabb JW, ed. Techniques in Protein Chemistry VI. San Diego, CA: Academic Press; 1995:311-319.
20. Matrix Science Ltd. Mascot. http://www.matrix-science.com/ search_form_select.html. Accessed January 2005.
21. European Bioinformatics Institute. Swiss-Prot. http://www.ebi.ac.uk/ swissprot/. Accessed January 2005.
22. Boeckmann B, Bairoch A, Apweiler R, et al. The SWISS-PHOT protein knowledge database and its supplement TrEMBL in 2003. Nucleic Acids Res. 2003;31:365-370.
23. National Center for Biotechnology Information. NCBInr. http://www.protein.sdu.dk/gpmaw/GP-MAW/Databases/NCBInr/ncbinr.html. Accessed January 2005.
24. National Center for Biotechnology Information. EST: expression sequence tags database. http://www.ncbi.nlm.nih.gov/dbEST/. Accessed January 2005.
25. Gras R, Muller M, Gasteiger E, et al. Improving protein identification from peptide mass finger-printing through a parameterized multi-level scoring algorithm and an optimized peak detection. Electrophoresis. 1999;20:3535-3550.
26. Pilozzi E, Pulford K, Jones M, et al. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. J Pathol. 1998;186:140-143.
27. Pilozzi E, Muller-Hermelink HK, Falini B, et al. Gene rearrangements in T-cell lymphoblastic lymphoma. J Pathol. 1999;188:267-270.
28. Pollack JR, Sorlie T, Perou CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A. 2002;99:12963-12968.
29. Rubin MA, Varambally S, Beroukhim R, et al. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res. 2004;64:3814-3822.
30. Byrne JA, Mattei MG, Basset P. Definition of the tumor protein D52 (TPD52) gene family through cloning of D52 homologues in human (hD53) and mouse (mD52). Genomics. 1996;35:523-532.
31. Byrne JA, Nourse CR, Basset P, Gunning P. Identification of homo- and heteromeric interactions between members of the breast carcinoma-associated D52 protein family using the yeast two-hybrid system. Oncogene. 1998;16: 873-881.
32. Nourse CR, Mattei MG, Gunning P, Byrne JA. Cloning of a third member of the D52 gene family indicates alternative coding sequence usage in D52-like transcripts. Biochim Biophys Acta. 1998; 1443:155-168.
33. Sathasivam P, Bailey AM, Crossley M, Byrne JA. The role of the coiled-coil motif in interactions mediated by TPD52. Biochem Biophys Res Commun. 2001;288:56-61.
34. de Marco MC, Martin-Belmonte F, Kremer L, et al. MAL2, a novel raft protein of the MAL family, is an essential component of the machinery for transcytosis in hepatoma HepG2 cells. J Cell Biol. 2002;159:37-44.
35. Proux-Gillardeaux V, Galli T, Callebaut I, Mikhailik A, Calothy G, Marx M. D53 is a novel endosomal SNARE-binding protein that enhances interaction of syntaxin 1 with the synaptobrevin 2 complex in vitro. Biochem J. 2003;370:213-221.
36. Boutros R, Bailey AM, Wilson SH, Byrne JA. Alternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteins. J Mol Biol. 2003; 332:675-687.
37. Sun L, Bittner MA, Holz RW. Rim, a component of the presynaptic active zone and modulator of exocytosis, binds 14-3-3 through its N terminus. J Biol Chem. 2003;278:38301-38309.
38. Roth D, Burgoyne RD. Stimulation of catecholamine secretion from adrenal chromaffin cells by 14-3-3 proteins is due to reorganisation of the cortical actin network. FEBS Lett. 1995;374:77-81.
39. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002; 1:133-143.
40. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194:1625-1638.
41. Parente JA, Goldenring JR, Petropoulos AC, Hellman U, Chew CS. Purification, cloning, and expression of a novel, endogenous, calcium-sensitive, 28-kDa phosphoprotein. J Biol Chem. 1996; 271:20096-20101.
42. Groblewski GE, Yoshida M, Yao H, Williams JA, Ernst SA. Immunolocalization of CRHSP28 in exocrine digestive glands and gastrointestinal tissues of the rat. Am J Physiol. 1999;276:G219-G226.
43. Thomas DD, Taft WB, Kaspar KM, Groblewski GE. CRHSP-28 regulates Ca(2+)-stimulated secretion in permeabilized acinar cells. J Biol Chem. 2001;276:28866-28872.
44. Groblewski GE, Wishart MJ, Yoshida M, Williams JA. Purification and identification of a 28-kDa calcium-regulated heat-stable protein: a novel secretagogue-regulated phosphoprotein in exocrine pancreas. J Biol Chem. 1996;271:31502-31507.
45. Kaspar KM, Thomas DD, Taft WB, Takeshita E, Weng N, Groblewski GE. CaM kinase II regulation of CRHSP-28 phosphorylation in cultured mucosal T84 cells. Am J Physiol Gastrointest Liver Physiol. 2003;285:G1300-G1309.
46. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413-1420.
47. Schwering I, Brauninger A, Klein U, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2003;101:1505-1512.
48. Kuppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest. 2003;111:529-537.
49. Foss HD, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood. 1999;94:3108-3113.
50. Chilosi M, Adami F, Lestani M, et al. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol. 1999;12:1101-1106.